March 16, 2023 Archives

ART MEDICAL Announces Partnership With Teva Israel to Bring Its Lifesaving Technology to Critical Care Units

ART MEDICAL Ltd. is pleased to announce its collaboration with Teva Israel. Under the terms of the agreement, Teva Israel will market and distribute ART MEDICAL’s ground-breaking smART+ Platform in Israel’s intensive care units. NETANYA, ISRAEL / ACCESSWIRE / March 16, 2023 / The smART+ Platform is a robotic-assisted technology that aims to reduce complications […]

CONTINUE READING ➔

Sustainalytics Upgrades INNIO Group’s ESG Risk Rating From Low to Negligible Risk, Ranking INNIO Number 1 Worldwide Among Industry Peers

Sustainalytics ESG rating places INNIO in top 1 percentile of all industry peers and in top 2 percentile of companies rated by Sustainalytics on a global level. • INNIO receives Sustainalytics’ ESG risk score of 9.8, improving by 11% compared to 2022. • INNIO also receives Sustainalytics’ 2023 “ESG Industry Top rated” and “ESG Regional […]

CONTINUE READING ➔

De Novo Dairy Announces Rebrand and Headquarters Move to London

De Novo Dairy, a leading precision fermentation company, announced today its official rebrand to De Novo Foodlabs. The new name reflects the company’s expanded focus on creating sustainable nutrients that improve the health of people and the planet through precision fermentation and other technologies. LONDON, ENGLAND / ACCESSWIRE / March 16, 2023 / De Novo […]

CONTINUE READING ➔

AIM ImmunoTech Announces Late-Breaking Presentation at the International Conference on Antiviral Research Regarding Ampligen as a Potential Therapy Against Ebola Virus Disease

Growing body of data supports Ampligen’s potential as both a prophylactic and an early-onset therapy against human Ebola virus disease outbreaks OCALA, Fla., March 16, 2023 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of […]

CONTINUE READING ➔